|
1
|
Iorio MV, Casalini P, Piovan C, Braccioli
L and Tagliabue E: Breast cancer and microRNAs: Therapeutic impact.
Breast. 20(Suppl 3): S63–S70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Piovan C, Palmieri D, Di Leva G, Braccioli
L, Casalini P, Nuovo G, Tortoreto M, Sasso M, Plantamura I, Triulzi
T, et al: Oncosuppressive role of p53-induced miR-205 in triple
negative breast cancer. Mol Oncol. 6:458–472. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang D, Liu D, Gao J, Liu M, Liu S, Jiang
M, Liu Y and Zheng D: TRAIL-induced miR-146a expression suppresses
CxCR4-mediated human breast cancer migration. FEBS J.
280:3340–3353. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang S, Li Y, Gao J, Zhang T, Li S, Luo A,
Chen H, Ding F, Wang X and Liu Z: MicroRNA-34 suppresses breast
cancer invasion and metastasis by directly targeting Fra-1.
Oncogene. 32:4294–4303. 2013. View Article : Google Scholar
|
|
5
|
Sun EH, Zhou Q, Liu KS, Wei W, Wang CM,
Liu XF, Lu C and Ma DY: Screening miRNAs related to different
subtypes of breast cancer with miRNAs microarray. Eur Rev Med
Pharmacol Sci. 18:2783–2788. 2014.PubMed/NCBI
|
|
6
|
Mulrane L, Klinger R, Mcgee SF, Gallagher
WM and O’Connor DP: microRNAs: A new class of breast cancer
biomarkers. Expert Rev Mol Diagn. 14:347–363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barh D, Malhotra R, Ravi B and Sindhurani
P: MicroRNA let-7: An emerging next-generation cancer therapeutic.
Curr Oncol. 17:70–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar
|
|
9
|
Lane HA, Beuvink I, Motoyama AB, Daly JM,
Neve RM and Hynes NE: ErbB2 potentiates breast tumor proliferation
through modulation of p27(Kip1)-Cdk2 complex formation: Receptor
overexpression does not determine growth dependency. Mol Cell Biol.
20:3210–3223. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Motti ML, Califano D, Troncone G, De Marco
C, Migliaccio I, Palmieri E, Pezzullo L, Palombini L, Fusco A and
Viglietto G: Complex regulation of the cyclin-dependent kinase
inhibitor p27kip1 in thyroid cancer cells by the
pI3K/AKT pathway: Regulation of p27kip1 expression and
localization. Am J pathol. 166:737–749. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang XH, Cai P, Wang MH and Wang Z:
microRNA-25 promotes osteosarcoma cell proliferation by targeting
the cell cycle inhibitor p27. Mol Med Rep. 10:855–859.
2014.PubMed/NCBI
|
|
12
|
Tong J, Fu Y, Xu X, Fan S, Sun H, Liang Y,
Xu K, Yuan Z and Ge Y: TGF-β1 stimulates human Tenon’s capsule
fibroblast proliferation by miR-200b and its targeting of p27/kip1
and RND3. Invest Ophthalmol Vis Sci. 55:2747–2756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao ZQ, Shen Z and Huang WY: MicroRNA-802
promotes osteosarcoma cell proliferation by targeting p27. Asian
Pac J Cancer Prev. 14:7081–7084. 2013. View Article : Google Scholar
|
|
14
|
Wu X, Liu T, Fang O, Leach LJ, Hu X and
Luo Z: miR-194 suppresses metastasis of non-small cell lung cancer
through regulating expression of BMP1 and p27(kip1). Oncogene.
33:1506–1514. 2014. View Article : Google Scholar
|
|
15
|
Wang B, Li W, Guo K, Xiao Y, Wang Y and
Fan J: miR-181b promotes hepatic stellate cells proliferation by
targeting p27 and is elevated in the serum of cirrhosis patients.
Biochem Biophys Res Commun. 421:4–8. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sun M, Liu XH, Li JH, Yang JS, Zhang EB,
Yin DD, Liu ZL, Zhou J, Ding Y, Li SQ, et al: miR-196a is
upregulated in gastric cancer and promotes cell proliferation by
downregulating p27(kip1). Mol Cancer Ther. 11:842–852. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang C, Wang S, Zhao P, Wang X, Wang J,
Wang Y, Song L, Zou Y and Hui R: miR-221 promotes cardiac
hypertrophy in vitro through the modulation of p27 expression. J
Cell biochem. 113:2040–2046. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yi M, Parthiban P, Hwang J, Zhang X, Jeong
H, Park DH and Kim DK: Effect of a bispidinone analog on
mitochondria-mediated apoptosis in HeLa cells. Int J Oncol.
44:327–335. 2014.
|
|
19
|
Croce CM: Causes and consequences of
microRNA dysregulation in cancer. Nat Rev genet. 10:704–714. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu X, Liu L, Xu Q, Wu P, Zuo X and Ji A:
MicroRNA as a novel drug target for cancer therapy. Expert Opin
Biol Ther. 12:573–580. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen J, Wang BC and Tang JH: Clinical
significance of microRNA-155 expression in human breast cancer. J
Surg Oncol. 106:260–266. 2012. View Article : Google Scholar
|
|
22
|
Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J,
Zhao JJ, Mao SS, Zhang GH, Xu XC and Zhang N: miR-340 inhibition of
breast cancer cell migration and invasion through targeting of
onco-protein c-Met. Cancer. 117:2842–2852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24–2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar
|
|
24
|
Lal A, Navarro F, Maher CA, Maliszewski
LE, Yan N, O’Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O,
et al: miR-24 inhibits cell proliferation by targeting E2F2, MYC,
and other cell-cycle genes via binding to ̔seedless’ 3′UTR microRNA
recognition elements. Mol Cell. 35:610–625. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ciafrè SA, Galardi S, Mangiola A, Ferracin
M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM and Farace MG:
Extensive modulation of a set of microRNAs in primary glioblastoma.
Biochem Biophys Res Commun. 334:1351–1358. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Landgraf P, Rusu M, Sheridan R, Sewer A,
Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M,
et al: A mammalian microRNA expression atlas based on small RNA
library sequencing. Cell. 129:1401–1414. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Luo Q, Li X, Li J, Kong X, Zhang J, Chen
L, Huang Y and Fang L: miR-15a is underexpressed and inhibits the
cell cycle by targeting CCNE1 in breast cancer. Int J Oncol.
43:1212–1218. 2013.PubMed/NCBI
|
|
29
|
Shen L, Li J, Xu L, Ma J, Li H, Xiao X,
Zhao J and Fang L: miR-497 induces apoptosis of breast cancer cells
by targeting Bcl-w. Exp Ther Med. 3:475–480. 2012.PubMed/NCBI
|
|
30
|
Zhou P, Xu W, Peng X, Luo Z, Xing Q, Chen
X, Hou C, Liang W, Zhou J, Wu X, et al: Large-scale screens of
miRNA-mRNA interactions unveiled that the 3′UTR of a gene is
targeted by multiple miRNAs. PLoS One. 8:e682042013. View Article : Google Scholar
|
|
31
|
Bellan C, De Falco G, Lazzi S, Micheli P,
Vicidomini S, Schürfeld K, Amato T, Palumbo A, Bagella L, Sabattini
E, et al: CDK9/CYCLIN T1 expression during normal lymphoid
differentiation and malignant transformation. J Pathol.
203:946–952. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
De Falco G and Giordano A: CDK9: From
basal transcription to cancer and AIDS. Cancer biol Ther.
1:342–347. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
González T, Seoane M, Caamaño P, Viñuela
J, Domínguez F and Zalvide J: Inhibition of Cdk4 activity enhances
translation of p27kip1 in quiescent Rb-negative cells. J
biol Chem. 278:12688–12695. 2003. View Article : Google Scholar
|
